BRIEF-Vanc Pharma signs agreement for in-license on a CAD $150m generic molecule and soon to be off patent molecule
June 20 (Reuters) - Vanc Pharmaceuticals Signs Definitive Agreement For Exclusive In
* Vanc pharmaceuticals says entered into definitive agreement for filing two ands with exclusive marketing rights to canada from an unnamed manufacturer
* Says other product will become off patent in 2017
* License on a cad $150m generic molecule and soon to be off patent molecule Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2016 All rights reserved.